The maintenance dose is generally 1500mcg once a month, or at a schedule determined by the physician based on the patient's ongoing clinical needs and blood test results
It is also known as a stable gastric pentadecapeptide primarily because it is stable in human gastric juice, can cause an anabolic healing effect in both the upper and lower GI tract, has an antiulcer effect, and produces a therapeutic effect on inflammatory bowel disease (IBD)all again surprisingly free of side effects
10.1016/j.jff.2021.104611 99 WuS.XuY.ChenZ.ChenY.WeiF.XiaC.et al (2023)
Despite promising preclinical results and its favorable safety profile, BPC 157 lacks FDA approval, necessitating further clinical trials to validate its therapeutic potential and establish comprehensive safety data
Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice
Neuropeptide Y family of hormones: receptor subtypes and antagonists